Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Tobin W Juvenal is Chief Commercial Officer at Castle Biosciences. OQRO lists 14 transactions filed with the SEC under this name, the latest on Nov 13, 2026, each linked to the official Form 4.
Chief Commercial Officer
Disclosures on record
14
Companies involved
1
As of the latest filing on , Tobin W Juvenal reported holding 32,737 shares of Castle Biosciences (CSTL), worth about $1.11M at the last close of $34 (Nov 13, 2026). In the last 12 months, Tobin W Juvenal sold $1.01M in 9 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Castle Biosciences CSTL | 32,737 | 33K direct | $34 | $1.11M | Nov 11, 2026 |
Is this Tobin W Juvenal’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Castle BiosciencesCSTL
14 disclosures · Nov 2024 – Nov 2026 · 12 sold
Nov 11, 2026Sold~$112Kdisclosed Nov 13
DetailsOfficial recordNov 11, 20263,195disclosed Nov 13
DetailsOfficial recordNov 11, 20263,195disclosed Nov 13
DetailsOfficial recordNov 9, 2026Sold~$107Kdisclosed Nov 12
DetailsOfficial recordNov 11, 2026Sold~$99Kdisclosed Nov 12
DetailsOfficial recordOct 28, 2026Sold~$196Kdisclosed Oct 30
DetailsOfficial recordOct 28, 2026Sold~$44Kdisclosed Oct 30
DetailsOfficial recordOct 26, 2026Sold~$109Kdisclosed Oct 28
DetailsOfficial recordOct 12, 2026Sold~$111Kdisclosed Oct 14
DetailsOfficial recordSep 29, 2026Sold~$197Kdisclosed Oct 2
DetailsOfficial recordSep 30, 2026Sold~$35Kdisclosed Oct 2
DetailsOfficial recordJan 6, 2025Sold~$67Kdisclosed Jan 8
DetailsOfficial recordNov 5, 2024Sold~$125Kdisclosed Nov 7
DetailsOfficial recordNov 1, 2024Sold~$110Kdisclosed Nov 5
DetailsOfficial recordTobin W Juvenal has no open-market purchase on record since 2021. Sales in each of the last 3 years.
Tobin W Juvenal reported 0 open-market purchases and 13 sales since 2021; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $1.01M9×9 trades |
| 2025 | — | $67K1×1 trade |
| 2024 | — | $234K2×2 trades |
| 2021 | — | $754K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 11, 2026, Tobin W Juvenal reported holding 32,737 shares of Castle Biosciences (CSTL). At the last close of $34 on Nov 13, 2026, that is about $1.11M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Tobin W Juvenal reported 9 open-market sales worth $1.01M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Tobin W Juvenal has no open-market purchase on record since 2021. Sales in each of the last 3 years.
In SEC filings since 2021: no open-market purchase is on record; the latest open-market sale is from 2026.
Castle Biosciences (CSTL), from 2021 to 2026: 0 purchases and 13 sales.
Tobin W Juvenal reported 0 open-market purchases and 13 sales here, 2021 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
